We will be attending the ESC Congress in Munich – which has developed into the world’s largest conference in cardiovascular medicine – this August 25-29th.
We invite you to visit us at our booth D450 and hear more about our options for cardiovascular diseases.
Join us for a discussion
Stop by for our poster session, hosted by Blueprint Genetics’ Chief Medical Officer and Laboratory Director Juha Koskenvuo (MD, PhD), as he presents the topic of JPH2 p.(Thr161Lys) – a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities. Specific time will be included later.
Find out more information about ESC 2018 here and join the discussion #ESCCongress.
Interested to learn more about cardiovascular genetic testing?
Laboratory Director, Chief Medical Officer, co-founder of Blueprint Genetics (MD, Ph.D.)
Juha Koskenvuo is the Laboratory Director and Chief Medical Officer as well as the co-founder of Blueprint Genetics. He is responsible for supervising laboratory production and for designing new diagnostic tests.has a MD-PhD from the University of Turku. In 2006, he completed his fellowship program in clinical physiology and nuclear medicine. The following year, he became a docent. From 2007 to 2009, he joined the UCSF Cardiac Stem Cell Translational Development Program (California, USA) as a post-doctoral researcher and later as a research specialist.